Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label single-center mass balance study of AIC090019
NL-OMON34410Active, not recruiting
- Sponsor
- AiCuris
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of AIC090019 in hepatitis B (HBV), sponsored by AiCuris. Primary endpoints: Mass balance of AIC090019, Metabolite identification in plasma and excreta and 4 more. Started Oct 2010; status: active, not recruiting.
02
Drugs
AIC090019
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NL-OMON34410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34410.